Reply
By Laura Olson, Georgia Recorder
WASHINGTON Use of the Johnson & Johnson COVID-19 shot will remain paused for at least a week, after a federal vaccine advisory panel said Wednesday that it had too little data on a rare but serious blood-clotting condition reported in at least six women.
That means states and federally run vaccine sites will be relying on the other two authorized vaccines from Pfizer and Moderna until the panel meets again. The rare condition has not been reported following doses of those shots.
The Biden administration s COVID-19 response team has said there are enough doses available of Pfizer and Moderna to continue the current pace of vaccinations nationally.
Johnson & Johnson COVID-19 vaccine pause continues as officials ask for more data
An independent committee didn’t have enough information to make a decision
Share this story
Photo By Tom Williams/CQ-Roll Call, Inc via Getty Images
Use of the Johnson & Johnson COVID-19 vaccine remains paused in the United States as officials gather more information about the rare clots reported in six people who got the shot. An independent advisory committee to the Centers for Disease Control and Prevention said it didn’t have enough information yet to say which groups might be at risk of the clots or to recommend who should get this vaccine.
The Reno Gazette Journal will follow Catherine and Raleigh Pedersen as they face unbelievable odds to save their daughter Clara. It s a race against time to get treatment before she turns 2. Here s part two of their story about receiving the call and the plan.
1 p.m. April 9, 2021
Clara Pedersen doesn t know why she s sitting at the Lucile Packard Children’s Hospital at Stanford Medical Center in Palo Alto, Calif. right now.
But she s getting prep work in anticipation of receiving a $2.2 million lifesaving drug.
Clara will get the drug Saturday on her second birthday.
Clara was diagnosed with spinal muscular atrophy two weeks ago. The rare genetic disease is killing Clara’s nerve cells, causing her muscles to waste away.